Table 3.
Antifungals | Etest (direct and standardized) | Disk diffusion (direct and standardized) | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Categorical agreement (n) | Essential agreement (%) | CC | P | Categorical agreement (n) | CC | P | ||||||||||||||||||||
VME | ME | MiE | SD | NSD | DT | ST | DT | ST | DT | ST | VME | ME | MiE | DT | ST | DT | ST | |||||||||
DT | ST | DT | ST | DT | ST | DT | ST | DT | ST | DT | ST | DT | ST | DT | ST | |||||||||||
Fluconazole | 0 | 0 | 0 | 0 | 4 | 7 | 79.0 | 77.4 | 0.765 | 0.510 | <.001 | <.001 | 0 | 0 | 1 | 1 | 6 | 2 | −0.695 | −0.734 | <.001 | <.001 | ||||
Voriconazole | 0 | 1 | 2 | 15 | 10 | 77.4 | 85.5 | 0.896 | 0.898 | <.001 | <.001 | 0 | 0 | 2 | 0 | 4 | 4 | −0.458 | −0.492 | <.001 | <.001 | |||||
Posaconazole | 5 | 7 | 15 | 7 | 67.7 | 77.4 | 0.614 | 0.613 | <.001 | <.001 | ||||||||||||||||
Caspofungin | 0 | 0 | 0 | 6 | 9 | 17 | 74.2 | 50.0 | 0.489 | 0.361 | <.001 | .004 | ||||||||||||||
Anidulafungin | 0 | 0 | 1 | 0 | 2 | 5 | 67.7 | 83.9 | 0.505 | 0.709 | <.001 | <.001 | ||||||||||||||
Amphotericin B | 7 | 7 | 9 | 11 | 74.2 | 71.0 | 0.432 | 0.423 | <.001 | .001 |
VME, very major errors; ME, major errors; MiE, minor errors; SD, substantial differences; NSD, nonsubstantial differences; CC paired samples correlation coefficients between direct/standardized Etest/disk diffusion and reference methods; P values of ≤.05 indicate significant agreement.